Experiment summary for ENCSR338DUC
doi:10.17989/ENCSR338DUC
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- RAD21
- Biosample summary
- Homo sapiens HepG2 genetically modified (insertion) using CRISPR targeting H. sapiens RAD21
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- HepG2 immortalized cell line stably expressing C-terminal eGFP-RAD21 fusion protein.
- Nucleic acid type
- DNA
- Size range
- 450-650
- Platform
- Illumina HiSeq 4000
- Controls
Attribution
ENCODE4 project
- Lab
- Michael Snyder, Stanford
- Award
- UM1HG009442 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:HepG2_eGFP-RAD21_CRISPR_ChIP
- Date submitted
- January 13, 2018
- Date released
- July 9, 2020
- Annotation (gkmsvm-model)
- Tags
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Antibody | Library |
|---|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens HepG2 cell line genetically modified (insertion) using CRISPR targeting H. sapiens RAD21 | ENCBS390CJI | ENCGM798LWU | ENCAB728YTO | ENCLB917JYN |
| 2 | 1 | Homo sapiens HepG2 cell line genetically modified (insertion) using CRISPR targeting H. sapiens RAD21 | ENCBS828BFU | ENCGM798LWU | ENCAB728YTO | ENCLB048WXW |